Bausch & Lomb's ReNu MoistureLoc linked to dangerous fungal infections
Chantix more effective than Zyban in clinical trials, agency says
Curbs nicotine withdrawal symptoms
Younger, more active people benefit most, maker says
New study contradicts earlier research with rats that found a link to cancer
Using medicines for non-approved reasons is legal but risky, experts say
Some with MDS need frequent blood transfusions
Cardiac group asks FDA and manufacturers to cooperate on pacemakers, defibrillators
But votes on drug approvals wouldn't change much if they withdrew from advisory panels, study finds
While supporters laud stance, opponents call drug a valuable tool
Alerts user when glucose drops too low
Despite controversy, decades-long study finds no link
Injectable form replaces need for daily pill
Antioxidants don't seem to drive probucol's effects, study finds
Already approved for sun-damaged skin
In U.S. study, it surpassed standard anti-rejection drug
Relenza already sanctioned to treat flu's symptoms
'Surrogate markers' could speed drugs to patients, experts say
Most research on safety issues has been conducted in children, they note
Instead calls for simpler language and more information on labeling
For people who can't tolerate liquid preparations
For women who have abnormal Pap test
Panelists agree benefits outweigh rare risk of brain infection
First new drug for these types of cancer in decades
Woman who died from rare infection shouldn't have been part of Tysabri study in first place, they note
But some risk exists so more evaluation is needed, experts say
In cases where other drugs don't work
Higher doses require dietary restrictions
Treats nasal allergy symptoms
Eraxis fights deadly blood infections common at hospitals
FDA elaborates on saccharin and aspartame
But others say Tysabri, now withdrawn from market, met standard data requirements
But a second study found no heightened risk, officials report
FDA to consider Tysabri's full return to market next month
FDA says they could be dangerous
Trial results look good, but experts say rimonabant isn't a 'magic bullet'
Prevents leading cause of diarrhea in kids
In close vote, committee recommends 'black box' label for methylphenidates such as Ritalin
It should benefit patients and help control potential outbreaks, officials say
Exubera, first drug of its kind, could mean an end to injections for millions with the disease
New findings could change FDA rules on claims made by soy products
First new delivery option in decades
Deprives tumors of blood and nutrients
Sutent works against stomach and kidney cancers
But as FDA weighs approval, critics voice concerns about Xenical
Certain over-the-counter products contain chemical that can damage ozone layer
FDA action is designed to help doctors and consumers, officials say
Measures key protein found in urine, raises rate of detection of disease
Agency warns of prescription mix-ups, but critics suspect an anti-import agenda
FDA initiatives designed to aid scientists in early stages of research